טוען...
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
BACKGROUND: The time by which prostate-specific antigen (PSA) screening advances prostate cancer diagnosis, called the lead time, has been reported by several studies, but results have varied widely, with mean lead times ranging from 3 to 12 years. A quantity that is closely linked with the lead tim...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2720697/ https://ncbi.nlm.nih.gov/pubmed/19276453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djp001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|